Sign in Create account

Syschem (India) Ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 531173
₹35.47
▼ -0.66 (-1.83%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
56/100
Moderate
Valuation
89/100
Undervalued
Momentum
69/100
Neutral

QVM read Cheap on its own multiples Quality Moderate, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹175 Cr
PE (TTM)
16.3
Industry median 36.1 (152 companies)
Price to Book
1.4
PEG (TTM)
0.0
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-34.2
Free Cash Flow
₹8 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
263.64%
as of March 31, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
1962.17%
as of March 31, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
69.49%
as of March 31, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
278.91%
as of March 31, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
78.96%
as of March 31, 2026
Industry median 14.05% (173 companies)
Current Ratio
1.34
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
7.53
as of March 31, 2026
Industry median 10.58 (182 companies)
Net Margin
0.70%
as of March 31, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
3.08%
as of March 31, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
2.60%
as of March 31, 2026
Industry median 12.41% (182 companies)
Return on Assets
3.25%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
13.25%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
7.75%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

5 of 7 met
  • Yes Net profit is higher than a year earlier in each of the last 4 quarters
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • No Return on equity is 15% or more (7.7%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

1 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • No Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

2 of 3 met
  • No 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

2 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Undervalued (below its own historical PE range))
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-1.8%
Low 35.3000 · High 37.0000
1W return
0.4%
Low 35.3000 · High 39.3000
1M return
14.9%
Low 28.8100 · High 39.3000
52W return
-34.2%
Low 28.8100 · High 39.3000
Lifetime High ₹71.1100 (Jan. 9, 2024)
Lifetime Low ₹0.3800 (March 24, 2009)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish2
Bearish4
5D
35.7
10D
34.5
20D
33.5
50D
36.2
100D
41.7
200D
51.1

Delivery and volume

Day avg. delivery
88.3%
Week avg. delivery
78.5%
Month avg. delivery
84.4%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

35.92
Pivot
First resistance36.55
Second resistance37.62
Third resistance38.25
First support34.85
Second support34.22
Third support33.15
Day RSI57.1
Day MFI68.3
Day MACD0.50
Day MACD signal-0.48

Beta

1M2.09
3M1.54
1Y1.54
3Y0.65

Price change analysis

↑ 14.9%
Over 1 Month
LowHigh
28.8139.30
↓ -34.2%
Over 3 Months
LowHigh
28.8139.30
↓ -34.2%
Over 6 Months
LowHigh
28.8139.30
↓ -34.2%
Over 1 Year
LowHigh
28.8139.30
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 16.3 (own history: 24.7–816.8)
Undervalued (below its own historical PE range)

Financials

View full financials, peers & valuation multiples →
Revenue (March 31, 2026)
₹248 Cr
Net profit (March 31, 2026)
₹2 Cr
Basic EPS (March 31, 2026)
₹0.4000

Ranks #124 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter60.15%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings decreased from 60.86% to 60.15% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 25 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
18 Dec 2023 SAVITA SHARMA Bulk Sell 445,000 50.1800 BSE
15 Dec 2023 SAVITA SHARMA Bulk Sell 316,377 50.1900 BSE
30 Aug 2022 NEGEN CAPITAL SERVICES PVT LTD Bulk Buy 156,188 45.2500 BSE
16 Jun 2022 KAMAL GADALAY Bulk Buy 140,071 23.5500 BSE
2 Jun 2022 SURESH GADALEY Bulk Buy 226,334 19.8500 BSE
29 Dec 2017 KANCHAN GUPTA Bulk Sell 105,412 11.3900 BSE
21 Oct 2015 RANJAN JAIN Bulk Sell 222,386 10.6000 BSE
19 Oct 2015 RANJAN JAIN Bulk Sell 88,024 11.9600 BSE
16 Oct 2015 RANJAN JAIN Bulk Sell 270,230 12.7100 BSE
8 Jan 2008 SHIV KUMAR Bulk Sell 570,263 3.7100 BSE

All bulk and block deals →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Anil Pesticides Ltd. to Syschem (India) Ltd.

All corporate actions →

Corporate Announcements

All 6 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 AGM/EGM Syschem India Ltd - 531173 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
30 Sep 2026 AGM/EGM Syschem India Ltd - 531173 - Shareholder Meeting / Postal Ballot-Outcome of AGM
29 Sep 2026 Company Update Syschem India Ltd - 531173 - Announcement Under Regulation 30: Clarification On Price Movement.
28 Sep 2026 Company Update Syschem India Ltd - 531173 - Clarification sought from Syschem India Ltd
15 Sep 2026 Insider Trading / SAST Syschem India Ltd - 531173 - Closure of Trading Window
4 Sep 2026 AGM/EGM Syschem India Ltd - 531173 - Shareholder Meeting/Postal Ballot: Newspaper Advertisements After Dispatch Of Notice To The Shareholders.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.00)
  • Strong revenue growth YoY (79.0%)

Weaknesses

  • Low Return on Equity (7.7%)
  • Thin net profit margin (0.7%)

Opportunities

  • PEG below 1 (0.01) -- earnings growth outpacing its own valuation

Threats

  • Down 34.2% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Syschem (India) Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.